Cargando…
Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
A master promoter of cell growth, mammalian target of rapamycin (mTOR) is upregulated in a large percentage of cancer cells. Still, targeting mTOR using rapamycin has a limited outcome in patients. Our recent results highlight the additional role of mTOR as a tumor suppressor, explaining these modes...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5462510/ https://www.ncbi.nlm.nih.gov/pubmed/28616576 http://dx.doi.org/10.1080/23723556.2017.1297284 |
_version_ | 1783242527548112896 |
---|---|
author | Villar, Victor H. Nguyen, Tra Ly Terés, Silvia Bodineau, Clément Durán, Raúl V. |
author_facet | Villar, Victor H. Nguyen, Tra Ly Terés, Silvia Bodineau, Clément Durán, Raúl V. |
author_sort | Villar, Victor H. |
collection | PubMed |
description | A master promoter of cell growth, mammalian target of rapamycin (mTOR) is upregulated in a large percentage of cancer cells. Still, targeting mTOR using rapamycin has a limited outcome in patients. Our recent results highlight the additional role of mTOR as a tumor suppressor, explaining these modest results in the clinic. |
format | Online Article Text |
id | pubmed-5462510 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-54625102018-03-03 Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR Villar, Victor H. Nguyen, Tra Ly Terés, Silvia Bodineau, Clément Durán, Raúl V. Mol Cell Oncol Author's View A master promoter of cell growth, mammalian target of rapamycin (mTOR) is upregulated in a large percentage of cancer cells. Still, targeting mTOR using rapamycin has a limited outcome in patients. Our recent results highlight the additional role of mTOR as a tumor suppressor, explaining these modest results in the clinic. Taylor & Francis 2017-03-03 /pmc/articles/PMC5462510/ /pubmed/28616576 http://dx.doi.org/10.1080/23723556.2017.1297284 Text en © 2017 The Author(s). Published with license by Taylor & Francis Group, LLC http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted. |
spellingShingle | Author's View Villar, Victor H. Nguyen, Tra Ly Terés, Silvia Bodineau, Clément Durán, Raúl V. Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR |
title | Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR |
title_full | Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR |
title_fullStr | Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR |
title_full_unstemmed | Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR |
title_short | Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR |
title_sort | escaping mtor inhibition for cancer therapy: tumor suppressor functions of mtor |
topic | Author's View |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5462510/ https://www.ncbi.nlm.nih.gov/pubmed/28616576 http://dx.doi.org/10.1080/23723556.2017.1297284 |
work_keys_str_mv | AT villarvictorh escapingmtorinhibitionforcancertherapytumorsuppressorfunctionsofmtor AT nguyentraly escapingmtorinhibitionforcancertherapytumorsuppressorfunctionsofmtor AT teressilvia escapingmtorinhibitionforcancertherapytumorsuppressorfunctionsofmtor AT bodineauclement escapingmtorinhibitionforcancertherapytumorsuppressorfunctionsofmtor AT duranraulv escapingmtorinhibitionforcancertherapytumorsuppressorfunctionsofmtor |